瑞思邁 RMD 深 滬
等待開盤 08-23 09:30:00 美东时间
293.62
+5.280
+1.83%
華盛通- 最 高293.75
- 今 開288.855
- 成交量 48.78万股
- 最 低 288.75
- 昨 收 288.34
- 總市值 431.62亿
- 52周最高 293.75
- 市盈率 靜 30.89
- 換手率 0.33%
- 52周最低 198.79
- 委 比 -21.95%
- 總股本 1.47亿
- 歷史最高 293.75
- 量 比 0.55
- 振 幅 1.73%
- 歷史最低 5.65
- 每 手 1
- 風險率 16.61%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Resmed Strengthens Innovation Leadership with Dual Red Dot Design Awards and 10,000 Patents and Designs
Resmed's AirTouch N30i nasal mask won two Red Dot Design Awards, recognizing its innovative design and medical excellence. The mask features Resmed's ComfiSoft fabric cushion and a breathable, layered design, offering enhanced comfort and effectiveness for CPAP therapy. Designed with patient experience in mind, it promotes better adherence to treatment, addressing a global health issue affecting over one billion people. Winning both the Red Dot a...
08-21 13:00
Resmed Announces Election of Nicole Mowad-Nassar to Board of Directors and Upcoming Retirement of Rich Sulpizio
Resmed announced the election of Nicole Mowad-Nassar to its board of directors, effective August 15, 2025, and the retirement of Rich Sulpizio after 20 years of service. Mowad-Nassar, a senior pharmaceutical executive with over three decades of experience in strategy, commercial operations, and digital innovation, joins Resmed's board and will serve on the Compensation and Leadership Development Committee. Sulpizio, who chaired multiple committee...
08-18 20:15
美股最新评级 | 交银国际维持京东“买入”评级，目标价40美元
财联社8月18日讯（编辑 齐灵） 以下为各家券商对美股的最新评级和目标价： 国泰海通给予铿腾电子（CDNS.O）增持评级，目标价392.13美元： 公司作为全球...
08-18 16:06
ResMed Updates Dividend Exchange Rate for ASX CDI Holders
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( ($AU:R...
08-18 06:47
ResMed Inc. Officer Plans Sale of Shares Under Rule 144
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( ($AU:R...
08-08 06:58
ResMed Inc. Reports Change in Beneficial Ownership
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( ($AU:R...
08-08 06:57
美股大行评级 | 花旗、小摩分别上调苹果目标价；瑞穗上调Robinhood目标价从99美元升至120美元
今日重点评级关注：花旗：维持Apellis Pharmaceuticals"买入"评级，目标价从46美元升至52美元；BTIG：维持Strategy"买入"评级，目标价从620美元升至700美元
08-04 09:30
The Analyst Verdict: ResMed In The Eyes Of 8 Experts
Across the recent three months, 8 analysts have shared their insights on ResMed...
08-02 03:03
Earnings Outlook For IDEXX Laboratories
IDEXX Laboratories (NASDAQ:IDXX) will release its quarterly earnings report on ...
08-01 22:06
